India: New Delhi to resume exports of Covid-19 vaccines

AstraZeneca vaccines at the Serum Institute of India in Pune, January 21, 2021 (Illustrative image).

AP - Rafiq Maqbool

Text by: RFI Follow

1 min

India has announced that it will resume exports of Covid-19 vaccines from October, five months after suddenly halting them to vaccinate its own population.

A relief, considering that India is one of the largest producers of these vaccines in the world, and was to be one of the largest contributors to the COVAX program, set up to facilitate vaccination in poor countries.


Read more

With our correspondent in India


Sébastien Farcis

A year ago, at the UN General Assembly, the Indian Prime Minister promised to save the world by sending Indian vaccines.

This vaccine diplomacy has partially failed, because India suddenly

stopped its exports of doses

against Covid-19, at the end of April, to use them on its own population, submerged by a new deadly wave of contamination.

As a result, only 66 million Indian doses were sent abroad, which is nine times less than its Chinese rival, for example.

The situation is now improving in India:

contamination has fallen, production has increased and nearly a quarter of Indian adults are fully vaccinated, with 800 million doses administered.

New Delhi therefore promises to relaunch its exports in October, without specifying the distribution.

Until now, 2/3 of the shipments were donations or bilateral sales, mainly for neighboring Asian countries, and 1/3 intended for the Covax program for poor countries.

These doses have mainly gone to the Democratic Republic of the Congo, Ethiopia and Nigeria.


To read also:


Vaccine against Covid-19: the UN calls for equitable access to Covax


Covid-19: the Covax initiative to vaccinate poor countries is slowing down


Receive all international news directly in your mailbox

I subscribe

Follow all the international news by downloading the RFI application


  • India

  • Coronavirus

  • Vaccines

  • Diplomacy